Death of an activist spotlights an SA Aids movement that is in turmoil

Organisation: Position: Deadline Date: Location:

MabeleThe recent death of HIV activist Prudence Mabele has highlighted the turmoil and divisions in the SA Aids movement, where the ANC government has started making references to activist organisations as Western-funded ‘Trojan horses’.

In the moments after Prudence Mabele died, HIV activist Phindi Mkhabela looked around the waiting room of a Johannesburg hospital and saw the faces of those who had gathered to keep vigil, of women, who turned to each other and asked: “But how will I tell my children?”

“That’s how Prudence was – she touched you, she touched your family, she touched your friends,” remembered Mkhabela, speaking at Mabele’s memorial. Bhekisisa reports that more than one hundred people filled Wits University’s main hall to commemorate Mabele, who passed away on 10 July from pneumonia following a struggle with tuberculosis (TB).

Mabele was a leading voice in South Africa’s struggle for HIV treatment after becoming one of the first women to publicly disclose her HIV-positive status in 1992. She went on to co-found a host of organisations such as the Treatment Action Campaign, the Positive Women’s Network and the Aids Consortium. The report says these groups would be pivotal in securing treatment but in producing waves of activists that, like Mabele, would go on to fight for the right to health as well as the rights of women and the LGBTI community at home and abroad.

The concept of intersectionality – or the idea that social categories such as race, class and gender create overlapping and yet independent systems of disadvantage – has seen a resurgence in popular culture. Mabele, a sangoma who preached the gospel of antiretrovirals early on, was the embodiment, said many.

“Nowadays, we have to teach activists about intersectionality. Prudence lived intersectionality – for her, every struggle was worth the passion,” remembered Lebo Ramafoko, CEO of the non-profit Soul City Institute for Social Justice.

The report says Mabele was a fighter, dogged in her pursuit of justice. She was also stylish, grinning in mint-green kimono, and matching lipstick and oversized cat-eye sun glasses in a photo posted on Facebook and also on Sunday’s programme. She loved being “Aunt Pru” to her friends’ children. And she had a horrible singing voice, her friends related.

But, the report says, like us all, she was fragile. HIV activist Phindile Malaza explained: “As much as it didn’t seem like it to the world, Pru was lonely. There was a void in her life that none of the spaces could fill. Even in her last days, she was alone. Maybe part of it was that she didn’t want people to see her at her weakest point. Even if she was sick, some of us who claimed to be her friends would never know.”

If the recent funeral of struggle stalwart Ahmed Kathrada offered an opportunity to reflect on the state of South African politics, then, the report says, Mabele’s memorial could be said to have done same for the country’s HIV response. Her death also comes at a time when HIV activists may be more politically divided than they have been in more than a decade.

In July, South Africa held its bi-annual national Aids conference. Mabele led protests against gender-based violence, draped in an activist t-shirt – one hand on a megaphone, the other motioning to the crowd as she hung out of the window of a South African Police Service car. In footage captured on a cell phone, she throws a mischievous look towards the camera.

The report says days later at the conference, South African National Aids Council deputy chair Mmapaseka Steve Letsike held a press conference in response in part to unhappiness among some sectors of civil society regarding the health department’s new HIV plan for 2017 to 2022. At the meeting, she requested that Parliament and the public protector investigate “the entire HIV sector in South Africa to see who is funded by whom and where the money is going”. In short, Letsike seems to draw on existing narratives of a Western-funded third force that have been used to discredit civil society.

In May, it was reported that that a confidential ANC report called such organisations “Trojan horses” that served a “subversive agenda”. But, the report says, it’s unlikely that any major HIV organisation has not benefited from Western funding in South Africa.

The US government has been one of the largest funders of South Africa’s HIV response, investing more than $5.6bn in the country since 2004. In 2017, it committed $483m to fighting HIV and TB in the country until September 2018, according to the US President’s Emergency Plan for Aids Relief (PEPFAR). South Africa also receives substantial support from the international financing mechanism, the Global Fund to Fight Aids, TB and Malaria.

At the conference, Letsike, who also chairs the civil society forum, had stern words for members of the forum who had concerns about the plan and who accused her of denying alleged conflicts of interest involving her media company: “Either you join us, or you move on.”

The report says the meeting was also the first time the national HIV body admitted that it, not Cabinet, had cut the call for the decriminalisation of sex work – a hallmark of HIV plans in the last decade – from the final draft. This followed weeks of outrage over the omission from many activists.

A scarcity of funding for HIV organisations was mentioned by several speakers at the memorial. Also, the report says, the scramble for resources between organisations, that may in part be fuelling divisions within civil society, is likely to intensify. PEPFAR plans, as well as the newest national HIV plan, call for more money to be invested in fewer, but high impact, projects. Both plans also suggest that money should largely be spent in high HIV prevalence areas – 27 to be exact. Organisations not working in these districts could, therefore, face a tougher time accessing funding through the usual large-scale funders, the report says.

Bhekisisa report

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.